Log in

Relevant bibliographies by topics / Nihon Seikō

Contents

Journal articles
Books

Academic literature on the topic 'Nihon Seikō'

Author: Grafiati

Published: 26 July 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Nihon Seikō.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Nihon Seikō"

1

OOKAWA, Shigeru, and Satoshi KITAZONO. "Production of Antimony Compounds at Nakase Refinery, Nihon Seiko Co., Ltd." Journal of MMIJ 123, no. 12 (2007): 715–18. http://dx.doi.org/10.2473/journalofmmij.123.715.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

MIYAKE, A. "Shir zu sengo Nihon shakai no rekishi, 1. Kawaru shakai, kawaru hitobito: 20-seiki no naka no sengo Nihon (The Social History of Postwar Japan, Vol. 1. Changing Society, Changing Individuals: Japan's Postwar 20th Century)." Social Science Japan Journal 18, no. 1 (2014): 109–12. http://dx.doi.org/10.1093/ssjj/jyu028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Grachyov, Maxim. "Ideas About Natural Disasters as the “Natural Course of Things” and “Sango Years” in Ancient and Early Medieval Japan." ISTORIYA 13, no. 12-1 (122) (2022): 0. http://dx.doi.org/10.18254/s207987840023889-6.

Full text

Abstract:

The perception of natural disasters as a manifestation of work of supernatural forces was spread around the world during those periods of history when scientific knowledge was not developed enough to explain the mechanisms of natural phenomena. Japan, due to its geographical features, was regularly prone to all kinds of destructive natural forces, so it was it was touched by these ideas as well. The view on natural disasters as a form of divine retribution from Heaven for “immoral” ruling has been known in Japan since the establishment of the “state based on laws” (ritsuryo kokka), and often a

APA, Harvard, Vancouver, ISO, and other styles

4

KONDO, Ayako. "Seiki no Sekai • Hiseiki no sekai: Gendai nihon rōdō keizaigaku no kihon mondai (The World of Regular Employees The World of Non-regular Employees: Fundamental Issues in Labor Economics in Japan Today)." Social Science Japan Journal 22, no. 1 (2019): 172–76. http://dx.doi.org/10.1093/ssjj/jyy055.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Nagane, Motoo, Yoshitaka Narita, Kazuhiko Mishima, et al. "Phase 1/2 Study of Tirabrutinib (ONO/GS-4059), a Next-Generation Bruton's Tyrosine Kinase (BTK) Inhibitor, Monotherapy in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)." Blood 134, Supplement_1 (2019): 1586. http://dx.doi.org/10.1182/blood-2019-123362.

Full text

Abstract:

BACKGROUND The first-generation Bruton's tyrosine kinase (BTK) inhibitor ibrutinib is effective in patients with relapsed/refractory (r/r) primary central nervous system lymphoma (PCNSL). Tirabrutinib is a second-generation oral BTK inhibitor with greater selectivity than ibrutinib. We evaluated the safety, tolerability, efficacy, and pharmacokinetics (PK) of tirabrutinib once daily (QD) as monotherapy in patients with PCNSL to investigate BTK targeting as a novel therapeutic strategy. This multicenter clinical trial was sponsored by Ono Pharmaceutical Co., Ltd. and was conducted in Japan. MET

APA, Harvard, Vancouver, ISO, and other styles

6

Boot, W. J. "Nihon seiji shisōshi: 17–19 seiki 日本政治思想史――十七〜十九世紀. By Watanabe Hiroshi 渡辺浩. Tokyo: Tōkyō Daigaku Shuppankai, 2010. Pp. 484. ISBN 10: 4130331000; 13: 9784130331005." International Journal of Asian Studies 10, № 1 (2013): 106–8. http://dx.doi.org/10.1017/s1479591412000332.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Terui, Yasuhito, Yoshitaka Narita, Motoo Nagane, et al. "Quality of Life and Karnofsky Performance Status in Patients with Relapse or Refractory Primary Central Nervous System Lymphoma during Phase I/II Study of Tirabrutinib." Blood 138, Supplement 1 (2021): 4561. http://dx.doi.org/10.1182/blood-2021-146439.

Full text

Abstract:

Abstract Background: Based on the results of a phase I/II study in Japan (Trial registration: JapicCTI-173646), tirabrutinib (TIR), a second-generation inhibitor of Bruton's tyrosine kinase, was approved in March 2020 for the treatment of relapsed or refractory primary central nervous system lymphoma (r/r PCNSL). We have previously reported overall response rate of 63.6% and manageable safety profile results of this study (Narita et al. Neuro Oncol. 2021;23(1):122-133). Further, one-year follow-up data after the last patient had enrolled showed that the effects of TIR persisted in r/r PCNSL pa

APA, Harvard, Vancouver, ISO, and other styles

8

Yamauchi, Nobuhiko, Dai Maruyama, Ilseung Choi, et al. "Impact of Prophylactic Antiviral Therapy on Clinical Outcomes of Hepatitis B Virus Surface Antigen Positive Patients with Diffuse Large B-Cell Lymphoma Treated with Rituximab-Containing Chemotherapy." Blood 132, Supplement 1 (2018): 4209. http://dx.doi.org/10.1182/blood-2018-99-114850.

Full text

Abstract:

Abstract <Introduction> Hepatitis B virus (HBV) surface antigen (HBsAg)-positive patients treated with anti-B-cell lymphoma therapy are at high risk of HBV reactivation; indeed, the incidence is as high as 60-80% without antiviral prophylaxis. Hepatitis caused by HBV reactivation usually leads to discontinuation of chemotherapy, which in itself may be fatal. Therefore, several guidelines recommend antiviral prophylaxis for HBsAg-positive patients treated with chemotherapy. However, there is limited evidence regarding the clinical impact of antiviral prophylaxis on HBV reactivation and su

APA, Harvard, Vancouver, ISO, and other styles

9

Ohmachi, Ken, Tomohiro Kinoshita, Kensei Tobinai, et al. "Randomized Phase II/III Study of Standard R-CHOP Versus CHOP Combined with Dose-Dense Weekly Rituximab (RW-CHOP) for Previously Untreated DLBCL: JCOG0601." Blood 132, Supplement 1 (2018): 4194. http://dx.doi.org/10.1182/blood-2018-99-110201.

Full text

Abstract:

Abstract Background: CHOP plus rituximab (R-CHOP) is the standard of care for previously untreated DLBCL. R-CHOP comprises CHOP and one-dose rituximab in each 21-day cycle; however, the schedule of rituximab administration has not been fully optimized. Dose-dense rituximab was expected to increase its peak concentration to enhance the synergistic effect with chemotherapy at early phase of treatment. To compare weekly administration of rituximab combined with CHOP (RW-CHOP) with standard R-CHOP in patients with previously untreated DLBCL, we conducted a multicenter, randomized phase II/III stud

APA, Harvard, Vancouver, ISO, and other styles

10

Fujimoto, Ayumi, Fumihiro Ishida, Koji Izutsu, et al. "Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Aggressive Natural Killer Cell Leukemia: An Advantage of Cord Blood Transplantation." Blood 134, Supplement_1 (2019): 2032. http://dx.doi.org/10.1182/blood-2019-122049.

Full text

Abstract:

Introduction Aggressive natural killer cell leukemia (ANKL) is a rare leukemic form of mature natural killer cell neoplasms that is closely associated with Epstein-Barr virus. ANKL presents a fulminant clinical course, resulting in a poor prognosis with a median overall survival of approximately 2 months. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is currently the only curative treatment, but the long-term outcomes after allo-HSCT remain unclear. Methods Using the national Japanese transplant registry database, the outcomes of 59 ANKL patients who underwent first allo-HSCT

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Nihon Seikō"

1

Wakita, Shigeru. Nihon no rōdō keizai shisutemu: Seikō kara heisoku e. Tōyō Keizai Shinpōsha, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Saitō, Naoki. Chiiki inobēshon no seikō yōin oyobi sokushin seisaku ni kansuru chōsa kenkyū: "jizokusei" aru Nihon-gata kurasutā keisei, tenkairon : saishū hōkoku. Monbu Kagakushō Kagaku Gijutsu Seisaku Kenkyūjo Dai 3 Chōsa Kenkyū Gurūpu, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Galeries nationales du Grand Palais (France), Rʹeunion des musʹees nationaux (France), and Kokuritsu Seiyō Bijutsukan Gakugeika, eds. Japonisumu Ten: 19-seiki Seiyō bijutsu e no Nihon no eikyō. Kokuritsu Seiyō Bijutsukan, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Yasuda, Chieko. Otoko no seiki wa owatta: Seiyō to Nihon to no sa. Horiuchi Shuppan, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Murakawa, Ichirō. Nihon no seitō. Maruzen Kabushiki Kaisha, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Maeda, Noboru. Chiiki inobēshon no seikō yōin oyobi sokushin seisaku ni kansuru chōsa kenkyū: Ōbei no senshin kurasutā jirei to Nihon no chiiki kurasutā hikaku o tōshite : chūkan hōkoku. s.n.], 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Iinkai, Nihon Denki Seiki Kabushiki Kaisha Shashi Henshū. Nihon Denki Seiki shichijūgonenshi. Nihon Denki Seiki Kabushiki Kaisha, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Naikakufu, Japan. Nihon 21-seiki bijon. s.n.], 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

1934-, Tsuchiya Moriaki, ed. Keieishi: Seiyō to Nihon. Yūhikaku, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Nihon Seikatsu Kyōdō Kumiai Rengōkai. Sōritsu 50-shūnen Kinen Rekishi Hensan Iinkai. Gendai Nihon Seikyō undōshi. Nihon Seikatsu Kyōdō Kumiai Rengōkai, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!